Imerys (NK) Q4 2025 earnings summary

Executive summary

• 2025 revenue was €3.385 billion, broadly flat year-over-year (-0.7% like-for-like), with Q4 at €800–801 million, reflecting firm pricing amid subdued industrial and construction demand in North America and Europe.

• Adjusted EBITDA for 2025 was €546 million, within guidance, despite €22 million negative FX impact and subdued industrial activity.

• Net income group share was negative €409 million, mainly due to a €467 million non-cash goodwill impairment in the Solutions for Refractory, Abrasives and Construction business.

• Free operating cash flow was €127 million before strategic CapEx; a €0.75 per share dividend was proposed, consistent with prior years.

• Project Horizon launched to structurally lower costs, targeting €50–60 million annual savings, with over 50% of benefits expected in 2026 and full effect in 2027.

Financial highlights

• Group sales declined 0.7% like-for-like; adjusted EBITDA margin was 16.1%, down from 18.7% in 2024.

• Net income, group share, was a loss of €409 million, impacted by impairment and project-related write-offs.

• Net financial debt increased to €1,391 million, with a net debt/EBITDA ratio of 2.5x; investment grade ratings confirmed.

• Strong liquidity with €960 million in credit lines and €819 million in cash at year-end.

• Currency effects reduced revenue by €82 million, mainly due to USD devaluation.

Outlook and guidance

• No formal 2026 guidance provided; management remains prudent due to slow market recovery, especially in the U.S. and automotive sectors.

• Over 50% of Project Horizon cost savings expected in 2026, with full impact in 2027.

• CapEx for 2026 expected in the €200–270 million range, with no strategic CapEx planned.

• Disciplined execution and innovation remain key priorities.

• Construction in Europe expected to improve, while U.S. recovery remains uncertain.